Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
2.990
-0.020 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 76 employees as of December 31, 2023. The number of employees decreased by 13 or -14.61% compared to the previous year.
Employees
76
Change (1Y)
-13
Growth (1Y)
-14.61%
Revenue / Employee
$1,064,092
Profits / Employee
-$235,697
Market Cap
161.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Organigram Holdings | 984 |
The Joint | 794 |
2seventy bio | 274 |
Gossamer Bio | 135 |
Alpha Tau Medical | 121 |
MediWound | 100 |
Lineage Cell Therapeutics | 75 |
FULC News
- 7 days ago - Fulcrum Therapeutics, Inc. (FULC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference - GlobeNewsWire
- 15 days ago - Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET - GlobeNewsWire
- 5 weeks ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - FMR LLC's Strategic Reduction in Fulcrum Therapeutics Inc Shares - GuruFocus
- 7 weeks ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Fulcrum Therapeutics Inc For Possible Securities Fraud - Accesswire
- 7 weeks ago - Fulcrum Therapeutics, Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation - Accesswire
- 7 weeks ago - Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Fulcrum Therapeutics Inc For Possible Securities Fraud - Accesswire